According to Latest Report Study, the global DNA synthesis market was surpassed at USD 260.7 million in 2021 and is expected to hit around USD 513.80 million by 2030, growing at a CAGR of 7.83% from 2022 to 2030.
According to Latest Report Study, the global DNA synthesis market was surpassed at USD 260.7 million in 2021 and is expected to hit around USD 513.80 million by 2030, growing at a CAGR of 7.83% from 2022 to 2030.
DNA replication is the natural process of DNA synthesis. However, in the laboratory DNA is produced using genetic engineering and enzyme chemistry, artificially. This deoxyribonucleotide are used in genetic engineering, diagnostics, therapeutic applications, academic, and industrial use. Cost per base pair, error rates, lengths, and throughput, are some of the basic parameters that confirm the quality of synthesis from different companies.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39798
Therapeutic application is continuously witnessing research and development for antibody discovery, immunology, cancer therapy, infectious disease, vaccines, and synthetic biology. The commercial growth of oligonucleotide therapeutics including miRNA inhibitors, siRNA, and oligos is supporting the growth of this segment. In comparison to traditional therapies, DNA synthesis therapeutic drugs have several potential and economic advantages. For instance, in September 2021, India gave emergency approval to Zydus Cadila’s ZyCoV-D, the first DNA vaccine, a highly stable, and cost-effective vaccine. Thus, the marketspace offers a lucrative opportunity for growth.
The application segment has been mainly categorized as:
- Research and Development
- Academic
- Industrial
- Diagnosis
- Therapeutics
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 260.7 million |
| Revenue Forecast by 2030 | USD 513.80 million |
| Growth rate from 2022 to 2030 | CAGR of 7.83% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Service Type, Application, End User, Region |
| Companies Covered | Thermo Fisher Scientific, Inc., Twist Bioscience, Bioneer Corporation, Eton Bioscience, LGC Biosearch Technologie, IBA GmbH, Eurofins Scientific, Integrated DNA Technologies, Inc., Quintara Biosciences, GenScript Biotech Corporation, and others |
Furthermore, the human genome project is offering several advantages in technological processes for production and reduces the time of production. This enables the synthesis of the required sequence in the required time of high throughput custom nucleotides, accelerating the market growth. In addition, the commercial success of the multi-billion dollar PCR industry and Next-generation sequencing is boosting the market growth.
Startups’ entry into the DNA synthesis market is providing improved procedures for synthesis and innovations in the medical field. For instance, as of September 2022, U.S.-based startupSiolta Therapeutics’ STMC-103H, is in phase 2 clinical investigation. Biologic drug STMC-103H has been investigated for Atopic Dermatitis and Type 1 hypersensitivity, catering to new opportunities for market growth.
Key market players are continuously upgrading manufacturing technologies to obtain high throughput and cost-controlled synthesis. In 2017, Illumina announced an investment of USD 82 million in Twist biosciences to support the development of new technology for silicon-based deoxyribonucleotides synthesis. These players are undertaking various strategic initiatives on branding, market penetration, mergers & collaborations, expansion of manufacturing facilities, and geographical expansion.
Key Players
- Thermo Fisher Scientific, Inc.
- Twist Bioscience
- Bioneer Corporation
- Eton Bioscience
- LGC Biosearch Technologie
- IBA GmbH
- Eurofins Scientific
- Integrated DNA Technologies, Inc.
- Quintara Biosciences
- GenScript Biotech Corporation
- others
Market Segmentation
- By Service Type
- Oligonucleotide Synthesis
- Universal Oligonucleotide Synthesis
- Custom Oligonucleotide Synthesis
- Gene Synthesis
- Custom Gene Synthesis
- Gene Library Synthesis
- By Application
- Research and Development
- Academic
- Industrial
- Diagnosis
- Therapeutics
- By End User
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39798
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/